Portage Biotech Announces Results for Fiscal Quarter Ended :

--Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting-- --Clinical...

Related Keywords

Canada , United States , Westport , Newfoundland , American , , Development Agreement , Linkedin , Society For Immunotherapy Of Cancer , American Society Of Clinical Oncology , Development Committee , Merck Co , Portage Biotech Inc , Clinical Development Goals On Producing Nine Phase , Merck Sharp Dohme Corp , Nasdaq , Lincoln Park Capital Fund , Pipeline Clinical Program , National Cancer Institute Collaboration Research , Updated Data , Clinical Collaboration Agreement Entered , Focused Clinical Development Goals , Producing Nine Phase , Multiple Tumor Types Over , Next Two , Biotech Inc , Asian Waters , Chief Executive Officer , Clinical Program Highlights , Quarter Ended September , Portage Biotech , Joint Development Committee , Clinical Oncology , Business Highlights , Tarus Therapeutics , Merck Sharp , Dohme Corp , Nasdaq Prtg , Nc ,